166 related articles for article (PubMed ID: 16272294)
1. Functional analysis of B and T lymphocyte attenuator engagement on CD4+ and CD8+ T cells.
Krieg C; Han P; Stone R; Goularte OD; Kaye J
J Immunol; 2005 Nov; 175(10):6420-7. PubMed ID: 16272294
[TBL] [Abstract][Full Text] [Related]
2. 4-1BB ligand induces cell division, sustains survival, and enhances effector function of CD4 and CD8 T cells with similar efficacy.
Cannons JL; Lau P; Ghumman B; DeBenedette MA; Yagita H; Okumura K; Watts TH
J Immunol; 2001 Aug; 167(3):1313-24. PubMed ID: 11466348
[TBL] [Abstract][Full Text] [Related]
3. Distinct expression and inhibitory function of B and T lymphocyte attenuator on human T cells.
Wang XF; Chen YJ; Wang Q; Ge Y; Dai Q; Yang KF; Fang-Xie ; Zhou YH; Hu YM; Mao YX; Zhang XG
Tissue Antigens; 2007 Feb; 69(2):145-53. PubMed ID: 17257317
[TBL] [Abstract][Full Text] [Related]
4. B and T lymphocyte attenuator is highly expressed on CMV-specific T cells during infection and regulates their function.
Serriari NE; Gondois-Rey F; Guillaume Y; Remmerswaal EB; Pastor S; Messal N; Truneh A; Hirsch I; van Lier RA; Olive D
J Immunol; 2010 Sep; 185(6):3140-8. PubMed ID: 20693422
[TBL] [Abstract][Full Text] [Related]
5. Expression and function of the B and T lymphocyte attenuator (BTLA/CD272) on human T cells.
Otsuki N; Kamimura Y; Hashiguchi M; Azuma M
Biochem Biophys Res Commun; 2006 Jun; 344(4):1121-7. PubMed ID: 16643847
[TBL] [Abstract][Full Text] [Related]
6. B and T lymphocyte attenuator suppresses IL-21 production from follicular Th cells and subsequent humoral immune responses.
Kashiwakuma D; Suto A; Hiramatsu Y; Ikeda K; Takatori H; Suzuki K; Kagami S; Hirose K; Watanabe N; Iwamoto I; Nakajima H
J Immunol; 2010 Sep; 185(5):2730-6. PubMed ID: 20660710
[TBL] [Abstract][Full Text] [Related]
7. The poststimulation program of CD4 versus CD8 T cells (death versus activation-induced nonresponsiveness).
Tham EL; Mescher MF
J Immunol; 2002 Aug; 169(4):1822-8. PubMed ID: 12165505
[TBL] [Abstract][Full Text] [Related]
8. Therapeutic potential of B and T lymphocyte attenuator expressed on CD8+ T cells for contact hypersensitivity.
Nakagomi D; Suzuki K; Hosokawa J; Kobayashi Y; Suto A; Takatori H; Watanabe N; Matsue H; Murphy TL; Murphy KM; Shimada S; Nakajima H
J Invest Dermatol; 2013 Mar; 133(3):702-711. PubMed ID: 23190882
[TBL] [Abstract][Full Text] [Related]
9. B and T lymphocyte attenuator exhibits structural and expression polymorphisms and is highly Induced in anergic CD4+ T cells.
Hurchla MA; Sedy JR; Gavrieli M; Drake CG; Murphy TL; Murphy KM
J Immunol; 2005 Mar; 174(6):3377-85. PubMed ID: 15749870
[TBL] [Abstract][Full Text] [Related]
10. Multifaceted Role of BTLA in the Control of CD8
Ritthipichai K; Haymaker CL; Martinez M; Aschenbrenner A; Yi X; Zhang M; Kale C; Vence LM; Roszik J; Hailemichael Y; Overwijk WW; Varadarajan N; Nurieva R; Radvanyi LG; Hwu P; Bernatchez C
Clin Cancer Res; 2017 Oct; 23(20):6151-6164. PubMed ID: 28754817
[No Abstract] [Full Text] [Related]
11. PD-1:PD-L inhibitory pathway affects both CD4(+) and CD8(+) T cells and is overcome by IL-2.
Carter L; Fouser LA; Jussif J; Fitz L; Deng B; Wood CR; Collins M; Honjo T; Freeman GJ; Carreno BM
Eur J Immunol; 2002 Mar; 32(3):634-43. PubMed ID: 11857337
[TBL] [Abstract][Full Text] [Related]
12. B and T Lymphocyte Attenuator is a Target of miR-155 during Naïve CD4+ T Cell Activation.
Liu Y; Nie W; Jin Y; Zhuo A; Zang Y; Xiu Q
Iran J Immunol; 2016 Jun; 13(2):89-99. PubMed ID: 27350630
[TBL] [Abstract][Full Text] [Related]
13. Two-signal blockade with anti-CD45RB and anti-CD154 monoclonal antibodies inhibits graft rejection via CD4-dependent mechanisms in allogeneic skin transplantation.
Kim EY; Lee EN; Lee J; Park HJ; Chang CY; Jung DY; Choi SY; Lee SK; Joh JW; Kim SJ
Exp Mol Med; 2006 Jun; 38(3):284-94. PubMed ID: 16819287
[TBL] [Abstract][Full Text] [Related]
14. Blockade of T cell activation using a surface-linked single-chain antibody to CTLA-4 (CD152).
Griffin MD; Hong DK; Holman PO; Lee KM; Whitters MJ; O'Herrin SM; Fallarino F; Collins M; Segal DM; Gajewski TF; Kranz DM; Bluestone JA
J Immunol; 2000 May; 164(9):4433-42. PubMed ID: 10779742
[TBL] [Abstract][Full Text] [Related]
15. B and T lymphocyte attenuator-mediated signal transduction provides a potent inhibitory signal to primary human CD4 T cells that can be initiated by multiple phosphotyrosine motifs.
Chemnitz JM; Lanfranco AR; Braunstein I; Riley JL
J Immunol; 2006 Jun; 176(11):6603-14. PubMed ID: 16709818
[TBL] [Abstract][Full Text] [Related]
16. Detection of protein on BTLAlow cells and in vivo antibody-mediated down-modulation of BTLA on lymphoid and myeloid cells of C57BL/6 and BALB/c BTLA allelic variants.
del Rio ML; Kaye J; Rodriguez-Barbosa JI
Immunobiology; 2010 Jul; 215(7):570-8. PubMed ID: 19837478
[TBL] [Abstract][Full Text] [Related]
17. Patterns of costimulation of T cell clones by cross-linking CD3, CD4/CD8, and class I MHC molecules.
Wacholtz MC; Patel SS; Lipsky PE
J Immunol; 1989 Jun; 142(12):4201-12. PubMed ID: 2470819
[TBL] [Abstract][Full Text] [Related]
18. The capacity of the natural ligands for CD28 to drive IL-4 expression in naïve and antigen-primed CD4+ and CD8+ T cells.
Bian Y; Hiraoka S; Tomura M; Zhou XY; Yashiro-Ohtani Y; Mori Y; Shimizu J; Ono S; Dunussi-Joannopoulos K; Wolf S; Fujiwara H
Int Immunol; 2005 Jan; 17(1):73-83. PubMed ID: 15569772
[TBL] [Abstract][Full Text] [Related]
19. Distinct signal transduction in mouse CD4+ and CD8+ splenic T cells after CD28 receptor ligation.
Abe R; Vandenberghe P; Craighead N; Smoot DS; Lee KP; June CH
J Immunol; 1995 Feb; 154(3):985-97. PubMed ID: 7822814
[TBL] [Abstract][Full Text] [Related]
20. A humanised therapeutic CD4 mAb inhibits TCR-induced IL-2, IL-4, and IL-10 secretion and expression of CD25, CD40L, and CD69.
Woods M; Guy R; Waldmann H; Glennie M; Alexander DR
Cell Immunol; 1998 May; 185(2):101-13. PubMed ID: 9636688
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
